Abstract
Recombinant human Persephin (PSP) has been expressed at high levels in recombinant baculavirus infected Trichoplusia ni (Tn-5B1-4) cells. The expressed protein was purified by nickel affinity chromatography. Pure, recombinant human PSP promoted the survival of embryonic motor neurons in vitro but failed to protect adult rat spinal cord motor neurons after sciatic nerve transection in vivo. Because recombinant bioactive human PSP can be obtained in large quantities, and purified to near homogeneity, they are suitable for further biological activity investigation.
Keywords: human persephin, human persephin psp, trichoplusia ni, neurturin NTN
Protein & Peptide Letters
Title: Production, Purification, and Biological Activity Analysis of Recombinant Human Persephin Expressed in Insect Cells
Volume: 8 Issue: 2
Author(s): Zhe-Yu Chen, Xing-Dong Zheng, Li Cao, Chang-Lin Lu, Xiang-Fu Wu and Cheng He
Affiliation:
Keywords: human persephin, human persephin psp, trichoplusia ni, neurturin NTN
Abstract: Recombinant human Persephin (PSP) has been expressed at high levels in recombinant baculavirus infected Trichoplusia ni (Tn-5B1-4) cells. The expressed protein was purified by nickel affinity chromatography. Pure, recombinant human PSP promoted the survival of embryonic motor neurons in vitro but failed to protect adult rat spinal cord motor neurons after sciatic nerve transection in vivo. Because recombinant bioactive human PSP can be obtained in large quantities, and purified to near homogeneity, they are suitable for further biological activity investigation.
Export Options
About this article
Cite this article as:
Chen Zhe-Yu, Zheng Xing-Dong, Cao Li, Lu Chang-Lin, Wu Xiang-Fu and He Cheng, Production, Purification, and Biological Activity Analysis of Recombinant Human Persephin Expressed in Insect Cells, Protein & Peptide Letters 2001; 8 (2) . https://dx.doi.org/10.2174/0929866013409553
DOI https://dx.doi.org/10.2174/0929866013409553 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Glutamatergic Neurotransmission As Molecular Target of New Anticonvulsants
Current Topics in Medicinal Chemistry Regulation of GABA Neurotransmission by Glutamic Acid Decarboxylase (GAD)
Current Pharmaceutical Design Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Tryptamine Induces Axonopathy and Mitochondriopathy Mimicking Neurodegenerative Diseases via Tryptophanyl-tRNA Deficiency
Current Alzheimer Research Astrocyte-Microglia Cooperation in the Expression of a Pro-Inflammatory Phenotype
CNS & Neurological Disorders - Drug Targets Diabetes and Vascular Disease: Basic Concepts of Nitric Oxide Physiology, Endothelial Dysfunction, Oxidative Stress and Therapeutic Possibilities
Current Vascular Pharmacology Sex Hormones and their Analogues in Neuroimmune Biology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Small Molecules in Stem Cell Research
Current Pharmaceutical Biotechnology Drug Therapy of Neuropathic Pain: Current Developments and Future Perspectives
Current Drug Targets Neurodevelopment in Schizophrenia: The Role of the Wnt Pathways
Current Neuropharmacology Patent Selections
Recent Patents on Biotechnology Ghrelin as a Neuroprotective and Palliative Agent in Alzheimer's and Parkinson's Disease
Current Pharmaceutical Design Polyphenols Beyond Barriers: A Glimpse into the Brain
Current Neuropharmacology Imidazoline Receptors, Novel Agents and Therapeutic Potential
Cardiovascular & Hematological Agents in Medicinal Chemistry Pluripotency Crossroads: Junction of Transcription Factors, Epigenetic Mechanisms, MicroRNAs, and Long Non-coding RNAs
Current Stem Cell Research & Therapy Recent Patents on Drugs Addressing Neurodegenerative Diseases
Recent Patents on Biomarkers A Role for Leptin in the Systemic Inflammatory Response Syndrome (SIRS) and in Immune Response, an Update
Current Medicinal Chemistry High-Throughput Screening Technologies for Botulinum Neurotoxins
Current Topics in Medicinal Chemistry Exploring Molecular Approaches in Amyotrophic Lateral Sclerosis: Drug Targets from Clinical and Pre-Clinical Findings
Current Molecular Pharmacology Editorial
Current Medical Imaging